Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome

Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers

(2011) R. L. Milne et al.   ANNALS OF ONCOLOGY

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial

(2011) Pascal Pujol et al.   Familial Cancer

Prospective Study of Breast Cancer Incidence in Women With aBRCA1orBRCA2Mutation Under Surveillance With and Without Magnetic Resonance Imaging

(2011) Ellen Warner et al.   JOURNAL OF CLINICAL ONCOLOGY

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

(2011) Paul E. Goss et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bilateral prophylactic mastectomy in women with inherited risk of breast cancer – Prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery

(2010) Jessica Gahm et al.   BREAST

Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers

(2010) Victor R. Grann et al.   BREAST CANCER RESEARCH AND TREATMENT

EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients

(2010) Virginie Caux-Moncoutier et al.   HUMAN MUTATION

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The role of BRCA mutation testing in determining breast cancer therapy

(2010) Alison H. Trainer et al.   Nature Reviews Clinical Oncology

Uptake of Risk-Reducing Surgery in Unaffected Women at High Risk of Breast and Ovarian Cancer Is Risk, Age, and Time Dependent

(2009) D. G. R. Evans et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Female BRCA mutation carriers with a preference for prophylactic mastectomy are more likely to participate an educational-support group and to proceed with the preferred intervention within 2 years

(2009) Karin M. Landsbergen et al.   Familial Cancer

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers

(2009) Angela R Bradbury et al.   GENETICS IN MEDICINE

Survival Analysis of Cancer Risk Reduction Strategies forBRCA1/2Mutation Carriers

(2009) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

(2009) T. R. Rebbeck et al.   JNCI-Journal of the National Cancer Institute

Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007

(2008) Gordon F. Schwartz et al.   CANCER

Psychological Reactions, Quality of Life, and Body Image After Bilateral Prophylactic Mastectomy in Women At High Risk for Breast Cancer: A Prospective 1-Year Follow-Up Study

(2008) Yvonne Brandberg et al.   JOURNAL OF CLINICAL ONCOLOGY